Literature DB >> 9219745

Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET.

S Yamaguchi1, K Meguro, M Itoh, C Hayasaka, M Shimada, H Yamazaki, A Yamadori.   

Abstract

OBJECTIVE: To investigate the relation between atrophy of the hippocampus and parahippocampal gyrus (the % hippocampal area) and cerebral metabolic rate for glucose (CMRGlc) in Alzheimer's disease.
METHODS: 13 patients with probable Alzheimer's disease by NINCDS-ADRDA criteria (six men; seven women, mean age 71 years, mini mental state 13.8 (SD 4.6)) and age matched controls were studied. T1 weighted MRI (0.5T) images were used for evaluation of the hippocampal area. With a digitiser system, a percentage of the hippocampal area to the brain (the % hippocampal area) was calculated. Eight patients received another T1 weighted MRI (1.5T) for further evaluation of the minimum thickness of the hippocampus. Regional CMRGlc (rCMRGlc) was measured using PET and the FDG technique.
RESULTS: The hippocampal area in patients with Alzheimer's disease was significantly lower than that of controls (P < 0.01). All the cortical rCMRGlc values in patients with Alzheimer's disease were lower than those of controls (P < 0.01). A significant correlation (P < 0.05) was found between the % hippocampal area and rCMRGlc in the temporal lobe, temporoparieto-occipital (TPO) region, and frontal lobe in Alzheimer's disease. There was a significant correlation between minimal hippocampal thickness and ipsilateral TPO metabolism on both sides.
CONCLUSION: The ipsilateral correlation between hippocampal atrophy and decreased TPO metabolism in Alzheimer's disease suggests a functional relation and the asymmetries show that Alzheimer's disease is an asymmetric disease in its early stages.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9219745      PMCID: PMC1074143          DOI: 10.1136/jnnp.62.6.596

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  29 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Granulovacuolar degeneration in the ageing brain and in dementia.

Authors:  M J Ball; P Lo
Journal:  J Neuropathol Exp Neurol       Date:  1977-05       Impact factor: 3.685

3.  The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man.

Authors:  M Reivich; D Kuhl; A Wolf; J Greenberg; M Phelps; T Ido; V Casella; J Fowler; E Hoffman; A Alavi; P Som; L Sokoloff
Journal:  Circ Res       Date:  1979-01       Impact factor: 17.367

4.  Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography.

Authors:  R S Frackowiak; C Pozzilli; N J Legg; G H Du Boulay; J Marshall; G L Lenzi; T Jones
Journal:  Brain       Date:  1981-12       Impact factor: 13.501

5.  Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method.

Authors:  M E Phelps; S C Huang; E J Hoffman; C Selin; L Sokoloff; D E Kuhl
Journal:  Ann Neurol       Date:  1979-11       Impact factor: 10.422

6.  Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients. A quantitative study.

Authors:  M J Ball
Journal:  Acta Neuropathol       Date:  1978-05-24       Impact factor: 17.088

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography.

Authors:  T N Chase; N L Foster; P Fedio; R Brooks; L Mansi; G Di Chiro
Journal:  Ann Neurol       Date:  1984       Impact factor: 10.422

9.  Metabolic disturbances in exo-focal brain areas after cortical stroke studied by positron emission tomography.

Authors:  H Nagasawa; K Kogure; T Fujiwara; M Itoh; T Ido
Journal:  J Neurol Sci       Date:  1994-05       Impact factor: 3.181

10.  Ventricular size in patients with presenile dementia of the Alzheimer's type.

Authors:  M Albert; M A Naeser; H L Levine; A J Garvey
Journal:  Arch Neurol       Date:  1984-12
View more
  18 in total

Review 1.  Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Neurochem       Date:  2018-11-27       Impact factor: 5.372

Review 2.  Organic psychosis: Insight into the biology of psychosis.

Authors:  N T Lautenschlager; H Förstl
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

3.  The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer's disease.

Authors:  Sofie M Adriaanse; Koene R A van Dijk; Rik Ossenkoppele; Martin Reuter; Nelleke Tolboom; Marissa D Zwan; Maqsood Yaqub; Ronald Boellaard; Albert D Windhorst; Wiesje M van der Flier; Philip Scheltens; Adriaan A Lammertsma; Frederik Barkhof; Bart N M van Berckel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-11       Impact factor: 9.236

4.  Brain perfusion correlates of medial temporal lobe atrophy and white matter hyperintensities in mild cognitive impairment.

Authors:  Anna Caroli; Cristina Testa; Cristina Geroldi; Flavio Nobili; Ugo P Guerra; Matteo Bonetti; Giovanni B Frisoni
Journal:  J Neurol       Date:  2007-03-20       Impact factor: 4.849

5.  Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer's disease: comparison of a semiquantitative and a visual evaluation.

Authors:  W Staffen; U Schönauer; H Zauner; I Spindler; A Mair; B Iglseder; G Bernroider; G Ladurner
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

6.  Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.

Authors:  Joshua B Owen; Fabio Di Domenico; Rukhsana Sultana; Marzia Perluigi; Chiara Cini; William M Pierce; D Allan Butterfield
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

7.  Do cognitive patterns of brain magnetic activity correlate with hippocampal atrophy in Alzheimer's disease?

Authors:  F Maestú; J Arrazola; A Fernández; P G Simos; C Amo; P Gil-Gregorio; S Fernandez; A Papanicolaou; T Ortiz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

8.  Role of structural MRI in Alzheimer's disease.

Authors:  Prashanthi Vemuri; Clifford R Jack
Journal:  Alzheimers Res Ther       Date:  2010-08-31       Impact factor: 6.982

9.  Effects of medial temporal lobe degeneration on brain perfusion in amnestic MCI of AD type: deafferentation and functional compensation?

Authors:  Eric Guedj; Emmanuel J Barbeau; Mira Didic; Olivier Felician; Catherine de Laforte; Jean-Philippe Ranjeva; Michel Poncet; Patrick J Cozzone; Olivier Mundler; Mathieu Ceccaldi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-18       Impact factor: 9.236

10.  Cerebral perfusion (HMPAO-SPECT) in patients with depression with cognitive impairment versus those with mild cognitive impairment and dementia of Alzheimer's type: a semiquantitative and automated evaluation.

Authors:  W Staffen; J Bergmann; U Schönauer; H Zauner; M Kronbichler; S Golaszewski; G Ladurner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-10       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.